Insull W Jr - Search Results

1

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy.

Insull W Jr, Toth PP, Superko HR, Thakkar RB, Krause S, Jiang P, Parreno RA, Padley RJ. Insull W Jr, et al. Vasc Health Risk Manag. 2010 Nov 24;6:1065-75. doi: 10.2147/VHRM.S14053. Vasc Health Risk Manag. 2010. PMID: 21191426 Free PMC article. Clinical Trial.

2

Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study.

Insull W Jr, Basile JN, Vo AN, Jiang P, Thakkar R, Padley RJ. Insull W Jr, et al. J Clin Lipidol. 2009 Apr;3(2):109-18. doi: 10.1016/j.jacl.2009.02.009. Epub 2009 Feb 11. J Clin Lipidol. 2009. PMID: 21291800

3

Clinical management of atherosclerosis: a checklist.

Insull W Jr, Lewis SJ. Insull W Jr, et al. Am J Med. 2009 Jan;122(1 Suppl):S60-2. doi: 10.1016/j.amjmed.2008.10.018. Am J Med. 2009. PMID: 19110089

4

The pathology of atherosclerosis: plaque development and plaque responses to medical treatment.

Insull W Jr. Insull W Jr. Am J Med. 2009 Jan;122(1 Suppl):S3-S14. doi: 10.1016/j.amjmed.2008.10.013. Am J Med. 2009. PMID: 19110086 Review.

5

Introduction. Review of major recent findings supporting treatments to control advanced plaques of atherosclerosis.

Insull W Jr. Insull W Jr. Am J Med. 2009 Jan;122(1 Suppl):S1-2. doi: 10.1016/j.amjmed.2008.10.012. Am J Med. 2009. PMID: 19110083 No abstract available.

6

Achieving optimal lipid values in patients with dyslipidemia is associated with reduced risk of cardiovascular events.

Charland SL, Cziraky MJ, Quimbo R, Karas RH, Insull W Jr, Davidson M, Stanek EJ. Charland SL, et al. Among authors: insull w jr. J Clin Lipidol. 2008 Oct;2(5):343-53. doi: 10.1016/j.jacl.2008.06.009. Epub 2008 Jun 26. J Clin Lipidol. 2008. PMID: 21291759

7

Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.

Insull W Jr, Ghali JK, Hassman DR, Y As JW, Gandhi SK, Miller E; SOLAR Study Group. Insull W Jr, et al. Mayo Clin Proc. 2007 May;82(5):543-50. doi: 10.4065/82.5.543. Mayo Clin Proc. 2007. PMID: 17493418 Clinical Trial.

8

Dyslipidemia and auditory function.

Evans MB, Tonini R, Shope CD, Oghalai JS, Jerger JF, Insull W Jr, Brownell WE. Evans MB, et al. Among authors: insull w jr. Otol Neurotol. 2006 Aug;27(5):609-14. doi: 10.1097/01.mao.0000226286.19295.34. Otol Neurotol. 2006. PMID: 16868509 Free PMC article.

9

Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review.

Insull W Jr. Insull W Jr. South Med J. 2006 Mar;99(3):257-73. doi: 10.1097/01.smj.0000208120.73327.db. South Med J. 2006. PMID: 16553100 Review.

10

Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis.

Saam T, Kerwin WS, Chu B, Cai J, Kampschulte A, Hatsukami TS, Zhao XQ, Polissar NL, Neradilek B, Yarnykh VL, Flemming K, Huston J 3rd, Insull W Jr, Morrisett JD, Rand SD, DeMarco KJ, Yuan C. Saam T, et al. Among authors: insull w jr. J Cardiovasc Magn Reson. 2005;7(5):799-808. doi: 10.1080/10976640500287703. J Cardiovasc Magn Reson. 2005. PMID: 16353440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page